| What is new for an old molecule? Systematic review and recommendations on the use of resveratrol O Vang, N Ahmad, CA Baile, JA Baur, K Brown, A Csiszar, DK Das, ... PloS one 6 (6), e19881, 2011 | 538 | 2011 |
| A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine U Stervbo, O Vang, C Bonnesen Food Chemistry 101 (2), 449-457, 2007 | 355 | 2007 |
| Effects of dietary broccoli on human in vivo drug metabolizing enzymes: evaluation of caffeine, oestrone and chlorzoxazone metabolism MA Kall, O Vang, JØ Clausen Carcinogenesis 17 (4), 793-799, 1996 | 207 | 1996 |
| MicroRNA-29a is up-regulated in beta-cells by glucose and decreases glucose-stimulated insulin secretion A Bagge, TR Clausen, S Larsen, M Ladefoged, MW Rosenstierne, ... Biochemical and biophysical research communications 426 (2), 266-272, 2012 | 134 | 2012 |
| Challenges of translating basic research into therapeutics: resveratrol as an example JM Smoliga, O Vang, JA Baur Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2012 | 122 | 2012 |
| Resveratrol reverses tumor-promoter-induced inhibition of gap-junctional intercellular communication M Nielsen, RJ Ruch, O Vang Biochemical and Biophysical Research Communications 275 (3), 804-809, 2000 | 113 | 2000 |
| Induction of cytochrome P450IA1 in rat colon and liver by indole-3-carbinol and 5, 6-benzoflavone O Vang, MB Jensen, H Autrup Carcinogenesis 11 (8), 1259-1263, 1990 | 102 | 1990 |
| Time‐and concentration‐dependent effects of resveratrol in HL‐60 and HepG2 cells U Stervbo, O Vang, C Bonnesen Cell Proliferation 39 (6), 479-493, 2006 | 78 | 2006 |
| Induction of cytochrome P-450IA1, IA2, IIB1, IIB2 and IIE1 by broccoli in rat liver and colon O Vang, H Jensen, H Autrup Chemico-biological interactions 78 (1), 85-96, 1991 | 78 | 1991 |
| Collagen density modulates the immunosuppressive functions of macrophages AMH Larsen, DE Kuczek, A Kalvisa, MS Siersbæk, ML Thorseth, ... The Journal of Immunology 205 (5), 1461-1472, 2020 | 74 | 2020 |
| Modulation of cytochrome P-450 and glutathione S-transferase isoform expression in vivo by intact and degraded indolyl glucosinolates C Bonnesen, PU Stephensen, O Andersen, H Sorensen, O Vang Nutrition and cancer 33 (2), 178-187, 1999 | 68 | 1999 |
| N-methoxyindole-3-carbinol is a more efficient inducer of cytochrome P-450 1A1 in cultured cells than indol-3-carbinol PU Stephensen, C Bonnesen, C Schaldach, O Andersen, LF Bjeldanes, ... Nutrition and cancer 36 (1), 112-121, 2000 | 64 | 2000 |
| Biochemical effects of dietary intakes of different broccoli samples. I. Differential modulation of cytochrome P-450 activities in rat liver, kidney, and colon O Vang, H Frandsen, KT Hansen, O Andersen Metabolism-Clinical and Experimental 50 (10), 1123-1129, 2001 | 62 | 2001 |
| Characterization of the N-methoxyindole-3-carbinol (NI3C)–induced cell cycle arrest in human colon cancer cell lines AS Neave, SM Sarup, M Seidelin, F Duus, O Vang Toxicological sciences 83 (1), 126-135, 2005 | 59 | 2005 |
| Indolo[3,2- b ]carbazole inhibits gap junctional intercellular communication in rat primary hepatocytes and acts as a potential tumor promoter S Herrmann, M Seidelin, HC Bisgaard, O Vang Carcinogenesis 23 (11), 1861-1868, 2002 | 57 | 2002 |
| mTOR: more targets of resveratrol? AL Widlund, JA Baur, O Vang Expert reviews in molecular medicine 15, e10, 2013 | 55 | 2013 |
| What is new for resveratrol? Is a new set of recommendations necessary? O Vang Annals of the New York Academy of Sciences 1290 (1), 1-11, 2013 | 54 | 2013 |
| Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance (vol 5, pg 539, 2013) L Ye, AL Widlund, CA Sims, DW Lamming, Y Guan, JG Davis, ... AGING-US 12 (7), 6486-6487, 2020 | 53* | 2020 |
| Rapamycin doses sufficient to extend lifespan do not compromise muscle mitochondrial content or endurance AL Widlund, O Vang, L Ye, JA Baur, CA Sims, DW Lamming, Y Guan, ... Aging 5 (7), 539-550, 2013 | 53 | 2013 |
| Effects of dietary broccoli on human drug metabolising activity MA Kall, O Vang, J Clausen Cancer letters 114 (1-2), 169-170, 1997 | 53 | 1997 |
